Pathway Summary for TRAF6

Overview

TRAF6 (TNF Receptor-Associated Factor 6) is a critical E3 ubiquitin ligase and signal transduction adaptor that synthesizes K63-linked polyubiquitin chains for non-degradative signaling. It serves as a central hub connecting multiple immune signaling pathways including Toll-like receptors (TLRs), interleukin-1 receptor (IL-1R), TNF receptor superfamily, and T cell receptor (TCR) signaling. Unlike degradative K48-linked ubiquitination, TRAF6-mediated K63-linked chains serve as scaffolds for signal complex assembly.

Core Signaling Pathways

TLR/IL-1R Signaling Pathway

TRAF6 is recruited to TLR/IL-1R complexes via MyD88 and IRAK proteins. Upon activation, TRAF6 synthesizes K63-linked polyubiquitin chains that recruit TAB2/TAB3-TAK1 complex, leading to activation of NF-�B and MAPK pathways essential for inflammatory responses.

NF-�B Activation Pathway

TRAF6 activates NF-�B through multiple mechanisms:
- K63-ubiquitination of NEMO/IKK� facilitating IKK complex activation
- Self-ubiquitination creating docking sites for signaling complexes
- Activation of TAK1 which phosphorylates IKK�

RANKL/RANK Signaling

In osteoclast differentiation, RANKL binding to RANK recruits TRAF6, which activates NF-�B, MAPK, and NFATc1 pathways essential for osteoclastogenesis and bone remodeling.

Pathway Diagram

graph TD A[TLR/IL-1R] --> B[MyD88: Adaptor] B --> C[IRAK1/4: Kinases] C --> D[TRAF6: E3 Ligase] E[RANKL] --> F[RANK: Receptor] F --> D G[TCR/CD40] --> D D -->|K63-Ub chains| H[TAB2/3: Ub Sensors] H --> I[TAK1: Kinase] I --> J[IKK Complex] J --> K[NF-�B Activation] I --> L[MKK3/6] L --> M[p38 MAPK] I --> N[MKK4/7] N --> O[JNK] D -->|K63-Ub| P["NEMO/IKKγ"] P --> J Q[A20: DUB] -.->|removes K63-Ub| D R[CYLD: DUB] -.->|negative regulation| D K --> S[Inflammatory Genes] M --> T[Stress Response] O --> U[AP-1 Activation] style D fill:#f9f,stroke:#333,stroke-width:2px style K fill:#ffd,stroke:#333,stroke-width:1px

Upstream Activators

Pattern recognition receptors: TLRs recognizing PAMPs
Cytokine receptors: IL-1R, IL-17R, IL-18R
TNF receptor superfamily: RANK, CD40, BAFFR
Antigen receptors: TCR, BCR
Growth factor receptors: TGF-� receptor

Downstream Effects

NF-�B Target Genes

Inflammatory cytokines: IL-6, TNF-�, IL-1�
Chemokines: IL-8, MCP-1, RANTES
Adhesion molecules: ICAM-1, VCAM-1, E-selectin
Anti-apoptotic proteins: BCL-xL, c-IAP1/2

MAPK-Dependent Responses

AP-1 activation: via JNK pathway
Inflammatory mediators: via p38 MAPK
Cell survival and proliferation: via ERK pathway

Molecular Mechanisms

E3 Ligase Activity

RING domain: Catalyzes ubiquitin transfer
K63-linked chains: Non-degradative signaling scaffolds
Auto-ubiquitination: Self-modification for activation
Substrate specificity: NEMO, TAK1, self

Protein Interactions

TRAF domain: Receptor binding
Zinc fingers: Protein-protein interactions
Coiled-coil: Oligomerization

Clinical Significance

Disease Associations

Osteopetrosis: TRAF6 deficiency impairs osteoclastogenesis
Inflammatory diseases: Dysregulated TRAF6 in arthritis, IBD
Cancer: Overexpression in various malignancies
Immunodeficiency: Rare TRAF6 mutations

Therapeutic Targets

TRAF6 inhibitors: Anti-inflammatory therapy
Ubiquitination modulators: Cancer treatment
Pathway-specific targeting: Selective immunomodulation

Regulatory Mechanisms

Negative Regulation

A20 (TNFAIP3): Deubiquitinase removing K63 chains
CYLD: DUB specifically cleaving K63-linked chains
USP4: Deubiquitinates TRAF6
miR-146a: Post-transcriptional suppression

Positive Regulation

Pellino proteins: E3 ligases enhancing TRAF6 activity
TRIM proteins: Facilitate TRAF6 function
Phosphorylation: Enhances ligase activity

Tissue-Specific Functions

Immune cells: Inflammatory signaling, T cell activation
Bone: Osteoclast differentiation and function
Nervous system: Neuroinflammation, microglial activation
Epithelial cells: Barrier defense, wound healing

Cross-pathway Integration

TRAF6 integrates signals from:
1. Innate immunity: TLR signaling
2. Adaptive immunity: TCR/BCR signaling
3. Bone metabolism: RANK/RANKL axis
4. Cell survival: PI3K/AKT pathway
5. Autophagy: Beclin-1 ubiquitination